Rheumatology - Clinical Pharmacology News & Articles

1 Adherence to raloxifene therapy: assessment methods and relationship with efficacy Osteoporosis International, May 24, 2013    Clinical Article

2 Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice Clinical Rheumatology, May 24, 2013    Clinical Article

3 Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial Annals of Rheumatic Diseases, May 23, 2013    Clinical Article

4 Using actigraphy to measure sleep patterns in rheumatoid arthritis: A pilot study in patients taking night-time prednisone Musculoskeletal Care, May 23, 2013    Clinical Article

5 Steroid injection for inferior heel pain: a randomised controlled trial Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

6 Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

7 Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study) Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

8 Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

9 A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

10 Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

11 Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

12 Efficacy of rituximab in systemic manifestations of primary Sjogrens syndrome: results in 78 patients of the AutoImmune and Rituximab registry Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

13 Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry Annals of Rheumatic Diseases, May 22, 2013    Clinical Article

14 Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) Annals of Rheumatic Diseases, May 21, 2013    Clinical Article

15 A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Annals of Rheumatic Diseases, May 21, 2013    Clinical Article

16 Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study Annals of Rheumatic Diseases, May 21, 2013    Clinical Article

17 Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives Expert Opinion on Pharmacotherapy, May 21, 2013    Clinical Article

18 Behcet Disease-associated Uveitis Successfully Treated with Golimumab Ocular Immunology and Inflammation, May 21, 2013    Clinical Article

19 Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis Clinical and Experimental Rheumatology Online, May 20, 2013    Evidence Based Medicine    Review Article    Clinical Article

20 Validation of methotrexate-first strategy in early poor prognosis rheumatoid arthritis: Results from a randomized, double-blind, 2-year trial Arthritis & Rheumatism, May 20, 2013    Clinical Article

1 Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs Journal of Multidisciplinary Healthcare, April 5, 2013    Review Article    Clinical Guideline

2 Statin Use in Giant Cell Arteritis: A Retrospective Study The Journal of Rheumatology, April 3, 2013

3 Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells Annals of Rheumatic Diseases, April 10, 2013
Exclusive Author Commentary

4 Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up Rheumatology, April 1, 2013

5 Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial Annals of Rheumatic Diseases, April 8, 2013

6 Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis The Journal of Rheumatology, April 18, 2013    Evidence Based Medicine    Review Article

7 Sifalimumab, a human anti-interferon-a monoclonal antibody, in systemic lupus erythematosus: A phase 1 randomized controlled, dose-escalation study Arthritis & Rheumatism, February 13, 2013

8 Diclofenac in the treatment of osteoarthritis International Journal of Clinical Rheumatology, April 2, 2013

9 Profile of certolizumab and its potential in the treatment of psoriatic arthritis Drug Design, Development and Therapy, April 25, 2013    Free full text

10 Using cyclophosphamide in inflammatory rheumatic diseases European Journal of Internal Medicine , March 29, 2013    Review Article

11 Rationale for treating primary Sjogrens syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab) Immunologic Research, April 26, 2013    Review Article

12 Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review Seminars in Arthritis and Rheumatism, March 5, 2013    Evidence Based Medicine
Exclusive Author Commentary

13 A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate Annals of Rheumatic Diseases, April 22, 2013

14 Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over Osteoporosis International, March 20, 2013

15 Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus Erythematosus Clinical Therapeutics, April 29, 2013

16 A Comparison of the Efficacy of Dry Needling, Lidocaine Injection, and Oral Flurbiprofen Treatments in Patients with Myofascial Pain Syndrome: A Double-Blind (For Injection, Groups Only), Randomized Clinical Trial Turkish Journal of Rheumatology, March 21, 2013    Free full text

17 Longterm Effects of Rituximab on B Cell Counts and Autoantibody Production in Rheumatoid Arthritis: Use of High-sensitivity Flow Cytometry for More Sensitive Assessment of B Cell Depletion The Journal of Rheumatology, April 15, 2013

18 Tanezumab reduces osteoarthritic hip pain: Results of a randomized, double-blind, placebo-controlled phase 3 trial Arthritis & Rheumatism, April 2, 2013

19 Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study Annals of Rheumatic Diseases, April 11, 2013

20 Chronic Opioid Use in Fibromyalgia Syndrome: A Clinical Review JCR: Journal of Clinical Rheumatology, February 25, 2013    Review Article